by MM360 Staff | Apr 27, 2025 | Uncategorized
Source: CureToday articles Reflecting upon my relationship with Jill over the past 25 years, I am in awe of all she has accomplished. Read More
by MM360 Staff | Apr 26, 2025 | Uncategorized
Source: CureToday articles Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be presented at ASCO 2025. Read More
by MM360 Staff | Apr 26, 2025 | Uncategorized
Source: CureToday articles Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer. Read More
by MM360 Staff | Apr 25, 2025 | Uncategorized
Source: CureToday articles Mikela Pettigrew, B.S.N., RN, OCN,, exemplifies extraordinary compassion and dedication. Every day, she fulfills a promise she made as a young caregiver. Read More
by MM360 Staff | Apr 25, 2025 | Uncategorized
Source: CureToday articles Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemo. Read More
by MM360 Staff | Apr 25, 2025 | Uncategorized
Source: CureToday articles Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and provided subsequent updates. Read More
